Connect Biopharma Holdings logo

CNTB - Connect Biopharma Holdings News Story

$22.1 0.1  0.5%

Last Trade - 28/07/21

Mid Cap
Market Cap £884.3m
Enterprise Value £1.11bn
Revenue £n/a
Position in Universe 2686th / 7000

BRIEF-Connect Biopharma Announces First Patient Dosed In Phase 2 Trial Evaluating Cbp-201 In Adults With Moderate-To-Severe Persistent Asthma

Wed 12th May, 2021 2:25pm
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.